Scholarship

The "Women Scientists Scheme-A (WOS-A)" for research in basic and applied sciences has been evolved in this context, by the Department of Science and Technology (DST) for providing opportunities to women scientists and technologists between the age group of 27-57 years who desire to return to mainstream science and work as bench-level scientists.

Women Scientists Scheme (WOS) is a flagship programme of KIRAN Division of Department of Science & Technology (DST). Through one of its components- ‘Women Scientists Scheme-C (WOS-C)'- it provides one year on-the-job training in the area of Intellectual Property Rights (IPR). Patent Facilitating Centre (PFC) of Technology Information, Forecasting and Assessment Council (TIFAC) has been entrusted with implementation of WOS-C.

The Substance Abuse and Mental Health Services Administration (SAMHSA), Center for Substance Abuse Treatment (CSAT), is accepting applications for fiscal year (FY) 2018 Targeted Capacity Expansion:  Medication Assisted Treatment - Prescription Drug and Opioid Addiction (Short Title:  MAT-PDOA) grants.  The purpose of this program is to expand/enhance access to medication-assisted treatment (MAT) services for persons with an opioid use disorder (OUD) seeking or receiving MAT.  This program’s focus is on funding organizations and tribes/tribal organizations within states identified as having the highest rates of primary treatment admissions for heroin and opioids per capita and includes those states with the most dramatic increases for heroin and opioids, based on SAMHSA’s 2015 Treatment Episode Data Set (TEDS).  The desired outcomes include:  1) an increase in the number of individuals with OUD receiving MAT 3) a decrease in illicit opioid drug use and prescription opioid misuse at six-month follow-up.

Regional Centre for Biotechnology (RCB) is an institution of national importance, created by an Act of Parliament, established by Government of India through the Department of Biotechnology under the auspices of UNESCO. RCB has emerged as a pioneering institute for research in Biotechnology and is defining new horizons in providing world-class education, training and research at the interface of multiple disciplines for the benefit of mankind.

The Indian Council of Medical Research (ICMR), New Delhi, the apex body in India for the formulation, coordination and promotion of biomedical research, is one of the oldest medical research bodies in the world. As early as in 1911, the Government of India set up the Indian Research Fund Association (IRFA) with the specific objective of sponsoring and coordinating medical research in the country. After independence, several important changes were made in the organisation and the activities of the IRFA. It was redesignated in 1949 as the Indian Council of Medical Research (ICMR) with considerably expanded scope of functions.

We are a large, multi-disciplinary department, which aims to tackle some of the world’s biggest health challenges by integrating innovative basic biology with cutting edge clinical research. We have internationally renowned programmes in a range of areas including cardiovascular sciences, diabetes and endocrinology, immunology, haematology and pathology.  Formed in 2012, we are a multi-disciplinary department with research interests that span the translational spectrum – from basic biology through to clinical application. Our ultimate aim is patient benefit, through improved understanding, diagnosis and treatment of disease. Led by Prof Hugh Watkins, FRS, we are one of the largest departments in the University, with over 700 staff and an annual turnover of approximately £59m.

Novo Nordisk - Oxford Fellowship Programme

The Francis Crick Institute is a biomedical discovery institute dedicated to understanding the fundamental biology underlying health and disease. Its work is helping to understand why disease develops and to translate discoveries into new ways to prevent, diagnose and treat illnesses such as cancer, heart disease, stroke, infections, and neurodegenerative diseases.

One of the most notable developments in the S&T sector in the XI Plan has been the setting up of the Science and Engineering Research Board (SERB) through an Act of Parliament, viz. the Science and Engineering Research Board Act, 2008. Promoting basic research in Science and Engineering and to provide financial assistance to persons engaged in such research, academic institutions, research and development laboratories, industrial concerns and other agencies for such research and for matters connected therewith or incidental thereto are the primary and distinctive mandate of the Board.  SERB aims to build up best management systems which would match the best global practices in the area of promotion and funding of basic research.

TRAIN is a post-doctoral research program initiated by THSTI to impart training in translational research to candidates with doctoral degree in biological sciences. Selected candidates will be involved in large infectious disease research programs/projects involving human cohorts/clinical trials and are expected to work at the interface of biology and clinical research. Candidates will be jointly mentored by biologists and clinical researchers during the course of their fellowship. The focus areas include epidemiology, immunology, pathogenesis, drug and vaccine development, and diagnostics for viral and bacterial diseases (Eg: Dengue, Hepatitis, Pneumonia, Tuberculosis etc.)